How to buy China Biologic Products stock (CBPO)

China Biologic Products is a biotechnology business based in the US. China Biologic Products shares (CBPO) are listed on the NASDAQ and all prices are listed in US Dollars.

Our top picks for where to buy China Biologic Products stock

Buy China Biologic Products stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

China Biologic Products stock price (NASDAQ: CBPO)

Use our graph to track the performance of CBPO stocks over time.

China Biologic Products shares at a glance

• Key figures

Information last updated 2024-06-30.

52-week range	$0.00 - $0.00
50-day moving average more info button	$117.97
200-day moving average more info button	$117.60
Wall St. target price	$102.78
PE ratio more info button	31.411
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$3.82

Is it a good time to buy China Biologic Products stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is China Biologic Products stock undervalued or overvalued?

Valuing China Biologic Products stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of China Biologic Products's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

China Biologic Products's P/E ratio

China Biologic Products's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 31x. In other words, China Biologic Products shares trade at around 31x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

China Biologic Products's PEG ratio

China Biologic Products's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.53. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into China Biologic Products's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

China Biologic Products's EBITDA

China Biologic Products's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $222.6 million.

The EBITDA is a measure of a China Biologic Products's overall financial performance and is widely used to measure a its profitability.

China Biologic Products financials

Revenue TTM	$524.4 million
Operating margin TTM	37.26%
Gross profit TTM	$344.4 million
Return on assets TTM	5.82%
Return on equity TTM	9.25%
Profit margin	29.04%
Book value	$51.12
Market Capitalization more info button	$4.6 billion

TTM: trailing 12 months

China Biologic Products share dividends

We're not expecting China Biologic Products to pay a dividend over the next 12 months.

China Biologic Products share price volatility

Over the last 12 months, China Biologic Products's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while China Biologic Products's is 0.4242. This would suggest that China Biologic Products's shares are less volatile than average (for this exchange).

China Biologic Products overview

China Biologic Products Holdings, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China. It offers human albumin for treating shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia. The company also provides human immunoglobulin and IVIG for original and secondary immunoglobulin deficiency, auto-immune deficiency, and immunoglobulin G secondary deficiency; human hepatitis B immunoglobulin for the prevention of measles and contagious hepatitis; human rabies immunoglobulin primarily for passive immunity from bites or claws by rabies or other infected animals; and human tetanus immunoglobulin for the prevention and therapy of tetanus. In addition, it offers placenta polypeptide for the treatment of cell immunity deficiency diseases, viral infection, and leucopenia, as well as assists in postoperative healing; factor VIII for treating coagulopathies; human fibrinogen; and human prothrombin complex concentrate for treating congenital and acquired clotting factor II, VII, IX, X deficiency, as well as excessive anticoagulant, vitamin K deficiency, etc. Further, the company is developing Human fibrinogen for the treatment for lack of fibrinogen and increase human fibrinogen concentration; and artificial dura and spinal dura mater products for use in brain and spinal surgeries. The company sells its products directly, as well as through distributors.

Frequently asked questions

null
What percentage of China Biologic Products is owned by insiders or institutions?
Currently 45.077% of China Biologic Products shares are held by insiders and 51.031% by institutions. When does the fiscal year end for China Biologic Products?
China Biologic Products's fiscal year ends in December. Where is China Biologic Products based?
China Biologic Products's address is: Jialong International Tower, Beijing, China, 100125 What is China Biologic Products's ISIN number?
China Biologic Products's international securities identification number is: US16938C1062 What is China Biologic Products's CUSIP number?
China Biologic Products's Committee on Uniform Securities Identification Procedures number is: G21515104